A comparative economic analysis of simvastatin versus atorvastatin: results of the Surrogate Marker Cost-Efficacy (SMaC) study.

Source:http://linkedlifedata.com/resource/pubmed/id/10566573

Download in:

View as

General Info

PMID
10566573